Option holding - Company The number of options over ordinary shares in the company held during the financial year by each director and other members of key management personnel of the consolidated entity, including their personally related parties, is set out below: Balance at the start of the year Granted Exercised Expired / Forfeited / Other Balance at the end of the year Options over ordinary shares Mr. Boris Patkin 250,000 - - (250,000) - Dr. Gisela Mautner 2,135,000 - - (135,000) 2,000,000 2,385,000 - - (385,000) 2,000,000 This concludes the remuneration report, which has been audited. Shares under option Unissued ordinary shares of Noxopharm Limited under option at the date of this report are as follows: Grant date Expiry date Exercise price Number under option 1 February 2022 ** 1 February 2026 $0.5400 2,000,000 1 January 2025 10 September 2027 $0.1488 520,000 2,520,000 No person entitled to exercise the options had or has any right by virtue of the option to participate in any share issue of the company or of any other body corporate. ** Issued under the Noxopharm employee share plan. Shares issued on the exercise of options No ordinary shares of Noxopharm Limited were issued during the year ended 30 June 2025 and up to the date of this report on the exercise of options granted: Indemnity and insurance of officers The company has indemnified the directors and executives of the company for costs incurred, in their capacity as a director or executive, for which they may be held personally liable, except where there is a lack of good faith. During the financial year, the company has not paid a premium in respect of a contract to insure the officers of the company or any related entity. Indemnity and insurance of auditor The company has not, during or since the end of the financial year, indemnified or agreed to indemnify the auditor of the company or any related entity against a liability incurred by the auditor. During the financial year, the company has not paid a premium in respect of a contract to insure the auditor of the company or any related entity. Proceedings on behalf of the company No person has applied to the Court under section 237 of the Corporations Act 2001 for leave to bring proceedings on behalf of the company, or to intervene in any proceedings to which the company is a party for the purpose of taking responsibility on behalf of the company for all or part of those proceedings. Non-audit services There were no non-audit services provided during the financial year by the auditor. Annual Report 2025 21
RkJQdWJsaXNoZXIy MjE2NDg3